Parathyroid hormone receptor type 1/Indian hedgehog expression is preserved in the growth plate of human fetuses affected with fibroblast growth factor receptor type 3 activating mutations

American Journal of Pathology

Volumn 161, Issue 4, 2002, Pages 1325-1335

  Cormier, Sarah ^a   Delezoide, Anne Lise ^a   Benoist Lasselin, Catherine ^b   Legeai Mallet, Laurence ^b   Bonaventure, Jacky ^b   Silve, Caroline ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 3; PARATHYROID HORMONE RECEPTOR;

ACHONDROPLASIA; AGE; ARTICLE; CARTILAGE CELL; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; ENCHONDRAL OSSIFICATION; FETUS; GENE EXPRESSION; GENE MUTATION; GENOTYPE; GROWTH PLATE; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; THANATOPHORIC DWARFISM; VASCULARIZATION;

EID: 0036790460     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64409-4     Document Type: Article

References (50)

1. Baldet P: Le cartilage de croissance, développement, structure et dynamique. Notions Fondamentales en Orthopédie Edited by JG Pous, A Dimeglio, P Baldet, F Bonnel. Paris, Doin, 1980, pp 17-47
2. Caplan Al, Pechak DG: The cellular and molecular embryology of bone formation. Bone and Mineral Research, ed 5. Edited by WA Peck New-York Elsevier Science Publishers BV, 1987, pp 117-183
3. Olsen BR, Reginato AM, Wang W: Bone development. Annu Rev Cell Dev Biol 2000, 16:191-220
4. Hall B, Miyake T: All for one and one for all condensations and the initiation of skeletal development. Bioessays 2000, 22:138-147
5. Coutelier L: L’encoche d’ossification: aspect particulier de la croissance d’un os long Notions Fondamentales en Orthopédie. Edited by JG Pous, A Dimeglio, P Baldet, F Bonnel. Paris, Doin Editeurs, 1980, pp 48-56
6. Uhthoff H: The development of the limb buds. The growth of tubular bones. The Embryology of the Human Locomotor System. Berlin, Springer-Verlag, 1990, pp 7-24
7. Naski MC, Ornitz DM: FGF signaling in skeletal development. Front Biosci 1998, 3:D781-D794
8. Bonaventure J, Rousseau F, Legeai-Mallet L, Benoist C, Le Merrer M, Munnich A: Récepteurs des facteurs de croissance fibroblastiques (FGFR) et anomalies héréditaires de l’ossification endochondrale et membranaire. Med Sci 1996, 12:44-49
9. Ornitz DM: Regulation of chondrocyte growth and differentiation by fibroblast growth factor receptor 3. Novartis Found Symp 2001, 232:63-80
10. Xu X, Weinstein M, Li C, Deng C: Fibroblast growth factor receptors (FGFRs) and their roles in limb development. Cell Tissue Res 1999, 296:33-43
11. Webster MK, Donoghue DJ: FGFR activation in skeletal disorders: too much of a good thing. Trends Genet 1997, 13:178-182
12. Rousseau F, Saugier P, Le Merrer M, Munnich A, Delezoide AL, Maroteaux P, Bonaventure J, Narcy F, Sanak M: Stop codon FGFR3 mutations in thanatophoric dwarfism type 1. Nat Genet 1995, 10:11-12
13. Horton WA, Hood OJ, Machado MA, Campbell D: Growth plate cartilage studies in achondroplasia. Basic Life Sci 1988, 48:81-89
14. Horton WA, Hood OJ, Machado MA, Ahmed S, Griffey ES: Abnormal ossification in thanatophoric dysplasia. Bone 1988, 9:53-61
15. Ornoy A, Adomian GE, Eteson DJ, Burgeson RE, Rimoin DL: The role of mesenchyme-like tissue in the pathogenesis of thanatophoric dysplasia. Am J Med Genet 1985, 21:613-630
16. Rimoin DL, Hughes GN, Kaufman RL, Rosenthal RE, McAlister WH, Silberberg R: Endochondral ossification in achondroplastic dwarfism. N Engl J Med 1970, 283:728-735
17. van der Harten HJ, Brons JT, Dijkstra PF, Barth PG, Niermeyer MF, Meijer CJ, van Geijn HP, Arts NF: Some variants of lethal neonatal short-limbed platyspondylic dysplasia: a radiological ultrasonographic, neuropathological and histopathological study of 22 cases. Clin Dysmorphol 1993, 2:1-19
18. Delezoide AL, Lasselin-Benoist C, Legeai-Mallet L, Brice P, Senee V, Yayon A, Munnich A, Vekemans M, Bonaventure J: Abnormal FGFR 3 expression in cartilage of thanatophoric dysplasia fetuses. Hum Mol Genet 1997, 6:1899-1906
19. Delezoide AL, Benoist-Lasselin C, Legeai-Mallet L, Le Merrer M, Munnich A, Vekemans M, Bonaventure J: Spatio-temporal expression of FGFR 1, 2 and 3 genes during human embryo-fetal ossification. Mech Dev 1998, 77:19-30
20. Legeai-Mallet L, Benoist-Lasselin C, Delezoide AL, Munnich A. Bonaventure J: Fibroblast growth factor receptor 3 mutations promote apoptosis but do not alter chondrocyte proliferation in thanatophoric dysplasia. J Biol Chem 1998, 273:13007-13014
21. Naski MC, Colvin JS, Coffin JD, Ornitz DM: Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3. Development 1998, 125:4977-4988
22. Iwata T, Chen L, Li C, Ovchinnikov DA, Behringer RR, Francomano CA, Deng CX: A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos. Hum Mol Genet 2000, 9:1603-1613
23. Chen L, Adar R, Yang X, Monsonego EO, Li C, Hauschka PV, Yayon A, Deng CX: Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis. J Clin Invest 1999, 104:1517-1525
24. Henderson JE, Naski MC, Aarts MM, Wang D, Cheng L, Goltzman D, Ornitz DM: Expression of FGFR3 with the G380R achondroplasia mutation inhibits proliferation and maturation of CFK2 chondrocytic cells. J Bone Miner Res 2000, 15:155-165
25. Segev O, Chumakov I, Nevo Z, Givol D, Madar-Shapiro L, Sheinin Y, Weinreb M, Yayon A: Restrained chondrocyte proliferation and maturation with abnormal growth plate vascularization and ossification in human FGFR-3(G380R) transgenic mice. Hum Mol Genet 2000, 9:249-258
26. Wang Y, Spatz MK, Kannan K, Hayk H, Avivi A, Gorivodsky M, Pines M, Yayon A, Lonai P, Givol D: A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3. Proc Natl Acad Sci USA 1999, 96:4455-4460
27. Colvin JS, Bohne BA, Harding GW, McEwen DG, Ornitz DM: Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat Genet 1996, 12:390-397
28. Deng C, Wynshaw-Boris A, Zhou F, Kuo A, Leder P: Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 1996, 84:911-921
29. Strewler GJ: The physiology of parathyroid hormone-related protein. N Engl J Med 2000, 342:177-185
30. Philbrick WM, Wysolmerski JJ, Galbraith S, Holt E, Orloff JJ, Yang KH, Vasavada RC, Weir EC, Broadus AE, Stewart AF: Defining the roles of parathyroid hormone-related protein in normal physiology. Physiol Rev 1996, 76:127-173
31. Kronenberg HM, Chung U: The parathyroid hormone-related protein and Indian hedgehog feedback loop in the growth plate. Novartis Found Symp 2001, 232:144-152
32. Karaplis AC, Deckelbaum RA: Role of PTHrP and PTH-1 receptor in endochondral bone development. Front Biosci 1998, 3:D795-D803
33. St-Jacques B, Hammerschmidt M, McMahon AP: Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev 1999, 13:2072-2086
34. Chung Ui U, Schipani E, McMahon AP, Kronenberg HM: Indian hedgehog couples chondrogenesis to osteogenesis in endochondral bone development. J Clin Invest 2001, 107:295-304
35. Silve C, Jüppner J: Genetic disorders caused by mutations in the PTH/PTHrP receptor: Jansen’s metaphyseal chondrodysplasia and Blomstrand’s lethal chondrodysplasias. The Parathyroids. Edited by JP Bilezikian, R Marcus, M Levine. San Diego, Academic Press, 2001, pp 707-728
36. Oostra RJ, van der Harten JJ, Rijnders WP, Scott RJ, Young MP, Trump D: Blomstrand osteochondrodysplasia: three novel cases and histological evidence for heterogeneity. Virchows Arch 2000, 436:28-35
37. Li C, Chen L, Iwata T, Kitagawa M, Fu XY, Deng CX: A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors. Hum Mol Genet 1999, 8:35-44
38. Chen L, Li C, Qiao W, Xu X, Deng C: A Ser(365)->Cys mutation of fibroblast growth factor receptor 3 in mouse downregulates Ihh/PTHrP signals and causes severe achondroplasia. Hum Mol Genet 2001, 10:457-465
39. Rousseau F, Bonaventure J, Legeai-Mallet L, Pelet A, Rozet JM, Maroteaux P, Le Merrer M, Munnich A: Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 1994, 371:252-254
40. Wysolmerski JJ, Cormier S, Philbrick WM, Dann P, Zhang JP, Roume J, Delezoide AL, Silve C: Absence of functional type 1 parathyroid hormone (PTH)/PTH-related protein receptors in humans is associated with abnormal breast development and tooth impaction. J Clin Endocrinol Metab 2001, 86:1788-1794
41. Naski MC, Wang Q, Xu J, Ornitz DM: Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nat Genet 1996, 13:233-237
42. Wilcox WR, Tavormina PL, Krakow D, Kitoh H, Lachman RS, Wasmuth JJ, Thompson LM, Rimoin DL: Molecular, radiologic, and histopathologic correlations in thanatophoric dysplasia. Am J Med Genet 1998, 78:274-281
43. Legeai-Mallet L, Rossi A, Benoist-Lasselin C, Piazza R, Mallet JF, Delezoide AL, Munnich A, Bonaventure J, Zylberberg L: EXT 1 gene mutation induces chondrocyte cytoskeletal abnormalities and defective collagen expression in the exostoses. J Bone Miner Res 2000, 15:1489-1500
44. Aigner T, Loos S, Muller S, Sandeli LJ, Unni KK, Kirchner T: Cell differentiation and matrix gene expression in mesenchymal chondrosarcomas. Am J Pathol 2000, 156:1327-1335
45. Descalzi Cancedda F, Gentili C, Manduca P, Cancedda R: Hypertrophic chondrocytes undergo further differentiation in culture. J Cell Biol 1992, 117:427-435
46. Karaplis AC, Luz A, Glowacki J, Bronson RT, Tybulewicz VL, Kronenberg HM, Mulligan RC: Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev 1994, 8:277-289
47. Lanske B, Karaplis AC, Lee K, Luz A, Vortkamp A, Pirro A, Karperien M, Defize LH, Ho C, Mulligan RC, Abou-Samra AB, Juppner H, Segre GV, Kronenberg HM: PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science 1996, 273:663-666
48. Lanske B, Amling M, Neff L, Guiducci J, Baron R, Kronenberg HM: Ablation of the PTHrP gene or the PTH/PTHrP receptor gene leads to distinct abnormalities in bone development. J Clin Invest 1999, 104:399-407
49. McEwen DG, Green RP, Naski MC, Towler DA, Ornitz DM: Fibroblast growth factor receptor 3 gene transcription is suppressed by cyclic adenosine 3′, 5′-monophosphate. Identification of a chondrocytic regulatory element. J Biol Chem 1999, 274:30934-30942
50. Yoshida E, Noshiro M, Kawamoto T, Tsutsumi S, Kuruta Y, Kato Y: Direct inhibition of Indian hedgehog expression by parathyroid hormone (PTH)/PTH-related peptide and up-regulation by retinoic acid in growth plate chondrocyte cultures. Exp Cell Res 2001, 265:64-72